Concepedia

Publication | Open Access

Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

DOIFull Paper Access

136

Citations

30

References

2019

Year

Jhanelle E. Gray, Andreas Saltos, Tawee Tanvetyanon, Eric B. Haura, Ben Creelan, Scott Antonia, Michael Shafique, Hong Zheng, Wenjie Dai, James J. Saller,
Clinical Cancer Research

Abstract

Pembrolizumab plus vorinostat was well tolerated and demonstrated preliminary antitumor activity despite progression on prior ICI treatment.

References

YearCitations

Page 1